Jérôme Salomon
Jérôme Salomon is a French physician in infectious and tropical diseases and in public health who served as directeur général de la santé…
- Facts0
- Drivers0
- Indicators0
Jérôme Salomon is a French physician in infectious and tropical diseases and in public health who served as directeur général de la santé…
/1200x1200/774fc887-30c2-45ef-9e1d-73d2661fe8f3.jpg) Jérôme Salomon, French infectious-disease physician and public-health official.
Jérôme Salomon is a French physician in infectious and tropical diseases and in public health who served as directeur général de la santé, the health ministry’s director-general of health, from 8 January 2018. A decree of 3 January 2018, published in the Journal officiel on 4 January, appointed him to that post in succession to Benoît Vallet and described him as a professeur des universités–praticien hospitalier. He became nationally known during the COVID-19 pandemic in France as the official who delivered the evening epidemiological briefings.
A Parisian whose mother was a schoolteacher and whose father was a civil servant at the National Assembly, he studied medicine at Paris Descartes and graduated in 1996 with the congratulations of the jury and a silver medal, then specialised in public health while continuing clinical work. He practised in the infectious and tropical diseases service at the Raymond-Poincaré hospital in Garches and later held a university-hospital professorship there, together with an habilitation from the University of Versailles-Saint-Quentin-en-Yvelines, a doctorate in clinical epidemiology from Pierre-et-Marie-Curie University, a DESC in infectious and tropical diseases and a DES in public health. Before the director-generalship he advised Dominique Gillot in 1999, Bernard Kouchner in 2001 and Marisol Touraine from 2013, having first worked with Kouchner at the ministry in 1992; he also directed international projects at the Institut Pasteur, taught at the Conservatoire national des arts et métiers and chaired a Haute Autorité de santé working group on Lyme disease.
In that office the director-general implements ministerial policy, runs the central health administration and coordinates agencies including Santé publique France, the medicines agency, the French blood establishment and the regional health agencies, with health security among the core duties. On 27 January 2020, when France had three confirmed cases, he opened what became near-daily press briefings; during the first lockdown the 19:30 count of cases and deaths was a fixed point in the news, even after minister Olivier Véran said in mid-March that he would have preferred to end the nightly tally. A Senate inquiry report released on 10 December 2020 assigned him direct responsibility for the surgical-mask shortage, citing a fall in the strategic stock from 754 million masks at the end of 2017 to 100 million at the end of 2019, an order for 50 million replacements, a failure to inform minister Agnès Buzyn, and pressure to alter an expert report that had recommended a stock on the order of one billion masks.
On 17 April 2023 the World Health Organization appointed him assistant director-general for universal health coverage and for communicable and noncommunicable diseases, a portfolio covering HIV, viral hepatitis, sexually transmitted infections, tuberculosis, malaria, neglected tropical diseases, mental health, substance-use disorders and major noncommunicable diseases. The organization noted that he had sat on the WHO Executive Board and held a medical degree, a master’s degree in public health and a PhD in epidemiology. In December 2025 Health Policy Watch reported that he had been dropped from WHO’s senior leadership team in a May reshuffle and had left the organization in September.
Jérôme Salomon was born in Paris on 26 April 1969. Profiles published in 2020 place his parents in the civil service and teaching. L'Obs described his father as an administrateur at the National Assembly and his mother as a professeur; franceinfo, citing Le Monde, called her an institutrice and his father a fonctionnaire of the Assembly. He completed his secondary schooling at the lycée Lamartine in Paris before starting medicine.
On his mother's side he is a descendant of Alfred Dreyfus. In a December 2020 Paris Match account he called Dreyfus his great-great-grandfather, said he had grown up with Cinq années de ma vie—the memoir Dreyfus wrote as a prisoner on Devil's Island—and kept a photograph of him in his offices. The same article follows the line through Dreyfus's daughter Jeanne and her husband, the physician Pierre-Paul Lévy, whom it describes as the future inventor of a diphtheria vaccine. Their elder daughter lost her husband, a graduate of the École polytechnique, in a mountain accident in 1938, while she was pregnant with Danièle, Salomon's mother; their other daughter, Madeleine, was arrested by French police, deported to Auschwitz and died there at 25. Salomon told the magazine that he rarely mentioned the relationship.
He studied medicine at Paris Descartes University (Paris V, then commonly called Université René-Descartes). Franceinfo, drawing on a March 2020 Le Monde profile, reported that he graduated in 1996 with the congratulations of the jury and a silver medal. He was an intern of the Paris hospitals, specialized in public health. In a 2018 Les Echos portrait he recalled that his dean had rebuked the choice: public health was then treated as an obscure path for a candidate well ranked in the internat. His first intern posting, in 1994, was at the health ministry's Direction générale de la Santé. Work there on extractive growth hormone that had contaminated children led him to prion diseases, which became the subject of his medical thesis two years later. He described the passage of bovine spongiform encephalopathy to humans, as Creutzfeldt–Jakob disease, as the shock that made a population-level approach to health seem necessary in France.
The qualifications he has listed separately from that medical degree are a diplôme d'études spécialisées (DES) in public health and a diplôme d'études spécialisées complémentaires (DESC) in infectious and tropical diseases, a university doctorate in clinical epidemiology from Pierre and Marie Curie University (Paris 6), and an habilitation à diriger des recherches from the University of Versailles Saint-Quentin-en-Yvelines. The national catalogue records the doctoral thesis, Modification de l'usage antibiotique en population humaine et résistances bactériennes, as defended in 2008 at Paris 6 under Didier Guillemot, in clinical epidemiology. It frames bacterial resistance to antibiotics as a threat to public health and asks how much of the emergence and spread of resistance is attributable to antibiotic exposure, what its consequences are, and which control strategies work. The summary reports a study of about 2,500 children in which an antibiotic taken within 48 hours of a consultation for rhinopharyngitis was associated with a lower risk of a consultation for otitis within 14 days, particularly when the otitis was presumed bacterial. It also reports that repeated courses of antibiotics increased the selection of resistance without reducing infections, and that a weekly individual "antibiocycle" in people with spinal-cord injury appeared to reduce urinary infections and hospital admissions without acquisition of resistance.
Shorter press biographies have sometimes collapsed this sequence. L'Obs wrote that he left Paris René-Descartes a "doctor in epidemiology" and that he held a DES, rather than a DESC, in infectious and tropical diseases, while also noting a thesis on prion diseases. The faculty record cited by franceinfo, the 2008 catalogue entry and his academic profile keep the 1996 medical degree and the prion thesis distinct from the later doctorate in clinical epidemiology.
Jérôme Salomon was a specialty intern in the hospitals of Paris and the Île-de-France from 1994 to 1998 and a chef de clinique from 1999 to 2002, according to the career note the Ministry of Health issued when he was named director-general of health. Reporting on that appointment placed the 1999 post as chef de clinique-assistant at the Paris-Ouest faculty and in the infectious-diseases service of Hôpital Raymond-Poincaré in Garches, Hauts-de-Seine, within the Assistance publique – Hôpitaux de Paris (AP-HP). The same account said he held a diplôme d’études spécialisées complémentaires in infectious and tropical pathology.
The ministry biography states that he had been a praticien hospitalier at Raymond-Poincaré since 2002. A notice in the Journal officiel of 6 March 2003 recorded his inscription, after the 2002 session of the type-1 competition governed by the decree of 25 June 1999, on the aptitude list in epidemiology, health economics, prevention, biostatistics and medical informatics. Medscape reported that in 2004 he became president of the local committee against hospital-acquired infections at Garches, that in 2006 he was named referent physician for the coordination of infectious emergencies and epidemic and biological risk in Île-de-France, and that in 2016 he became president of the infection-control committee of the Paris-Ouest university hospitals. In a 2016 profile he said that he then chaired that hospital’s comité de lutte contre les infections nosocomiales and its commission on strategy, innovation, research and the university.
He was admitted, in the Journal officiel of 7 June 2015, to the type-1 competition for professeurs des universités–praticiens hospitaliers in infectious and tropical diseases. The decree published on 15 October 2015 named him in that grade, in the option of infectious diseases, and assigned him to the biology, pathology, forensic medicine and public-health cluster of Hôpital Raymond-Poincaré. The ministry’s communiqué of 3 January 2018 still described him as professeur des universités–praticien hospitalier in infectious and tropical diseases there, and the decree published on 4 January 2018, naming him director-general of health from 8 January, identified him by that university-hospital title.
His doctoral thesis, Modification de l’usage antibiotique en population humaine et résistances bactériennes, was submitted at Université Pierre-et-Marie-Curie (Paris 6) in clinical epidemiology, under Didier Guillemot. Theses.fr records it as number 2008PA066662, with the defence date entered as 1 January 2008. The summary treats antimicrobial resistance as a public-health threat and reports two lines of work: in about 2,500 children, an antibiotic within 48 hours of a consultation for rhinopharyngitis was associated with fewer otitis consultations over the next 14 days, and a weekly “antibiocycle” in people with spinal-cord injury was presented as cutting urinary infections and hospitalisations without new resistance.
The 2018 ministry note states that he held a university doctorate and an habilitation à diriger des recherches in epidemiology and was a researcher in the joint unit UMR 1181 (Inserm, Institut Pasteur and the University of Versailles Saint-Quentin-en-Yvelines), working on emerging diseases, epidemics and antibiotic resistance. In a 2016 profile he stated that he had been the French principal investigator of the European programme MOSAR (“Mastering Hospital Antimicrobial Resistance and its spread into the community”) and principal investigator of the regional hospital clinical-research programme ASAR (“Antibiotiques et Staphylococcus aureus résistant”).
Published MOSAR papers list J. Salomon among the authors of studies of resistant bacteria in rehabilitation centres. A 2012 paper by the MOSAR WP5 study team found methicillin-resistant S. aureus on admission in 105 of 1,204 patients (8.7 percent) screened in seven rehabilitation wards in four countries. A 2013 study in five rehabilitation units, including the Berck Maritime Hospital in France, examined 376 Escherichia coli isolates resistant to expanded-spectrum cephalosporins and found that sequence type ST131 accounted for 41.2 percent of them, with CTX-M-15 the most common β-lactamase.
A decree published on 22 December 2011 named him professeur des universités associé at half-time, in the scientific disciplines, at the Conservatoire national des arts et métiers (CNAM) for three years. A further decree, published on 29 September 2012, assigned him in the 67th section of the Conseil national des universités to the CNAM. That section is “Biologie des populations et écologie”. The ministry’s 2018 biography describes the CNAM appointment as a professorship in hygiene and safety in Paris from 2012 to 2015.
From the 2015 university-hospital appointment he taught at the UFR des sciences de la santé Simone Veil of the Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), which the ministry placed within Université Paris-Saclay. The 2016 profile lists him as professor of infectious and tropical diseases at UVSQ–Université Paris-Saclay and as an elected member of the university’s academic council and research commission, and records a diplôme d’études spécialisées in public health as well as the complementary diploma in infectious and tropical diseases.
The only cabinet appointment under Salomon's name in the Journal officiel nominations index for the late 1990s is a short one. An order published on 11 September 1999 made him a technical adviser to Dominique Gillot, secretary of state for health and social action in the government of Lionel Jospin; an order published on 9 November 1999 ended those functions on 31 October 1999. Later profiles describe a wider tie to Bernard Kouchner. Les Échos wrote in 2018 that Kouchner, then secretary of state for health, recruited him in 1999 as a public-health adviser and kept him until 2001, as the youngest of a circle that included Martin Hirsch, Didier Tabuteau, Dominique Martin and François Bourdillon. Franceinfo placed similar work in 1999 with Gillot and especially in 2001 with Kouchner, whom Salomon had met around 1992, during Kouchner's first period at the health ministry. Kouchner told the channel: "Jérôme, c'est mon élève, c'est mon bébé."
He returned to a ministerial office under Marisol Touraine. An order published on 26 April 2013 named him adviser in charge of health security, in place of Frédérik Staikowsky. A ministry page archived in August 2013 lists him in that post inside the cabinet's public-health and health-security unit. Hospimedia then described him as a hospital practitioner and, since 1 September 2012, a university professor at the Conservatoire national des arts et métiers in population biology. An order of 22 May 2015 ended the functions on 1 June 2015. Les Échos later wrote that from 2013 to 2015 he advised Touraine on epidemic risks including Ebola, Zika and chikungunya.
His account of prion disease, given to Les Échos, begins before those cabinets. A 1994 internship at the health directorate concerned extractive growth hormone that had contaminated children; prion diseases became the subject of his medical thesis two years later. He described the passage of bovine spongiform encephalopathy to people, and the first patients with Creutzfeldt–Jakob disease, as the point at which a population-level view of health became obvious in France. British projections of about 200,000 cases, he said, were not borne out: fewer than 300 were recorded worldwide. Franceinfo, writing about his time with Kouchner, put him on the front line of the aftermath of that crisis, of false anthrax letter alerts, and of an outbreak of Legionnaires' disease at the newly opened Hôpital européen Georges-Pompidou in Paris.
During the 2009 swine-flu pandemic his part was clinical and expert rather than ministerial. On 31 July 2009 Le Monde interviewed him as a public-health and infectious-disease specialist and as president of the nosocomial-infection committee at the Raymond-Poincaré university hospital, a referral centre for the Assistance publique–Hôpitaux de Paris. He said care had moved from a strictly hospital response toward community medicine, with hospitals reserved for fragile or severe cases. On 11 September 2009 Éditions Frison-Roche published La vérité sur la grippe A H1N1, 144 pages by Salomon and the virologist Bruno Lina on prevention, treatment, vaccination and management of the epidemic; the listing also credits Danielle Sommer. An order published on 11 December 2009 named him a qualified member of the Comité de lutte contre la grippe.
Les Échos attached three epidemic risks to the Touraine brief: the West African Ebola epidemic, chikungunya and Zika virus. It does not describe a separate operational command for him in any of the three.
From 2010 to 2012 he was responsible for international affairs at the Pasteur Institute. On 11 July 2011 the institute announced the association Pasteur International Network, grouping its 32 member institutes for joint research, public-health and training projects. Alice Dautry, the director-general, chaired it; Salomon, already head of the International Division, was executive director.
In October 2012 the institute dismissed him. Le Parisien reported in January 2021 that the official ground was "cause réelle et sérieuse", not fault or professional insufficiency: the institute judged his new CNAM professorship legally incompatible with the Pasteur post in working time, rest and the commitment required. The same investigation presented the exit as troubled. As Egora summarized that reporting, two women researchers received an anonymous typed letter accusing a senior official of sexual harassment, corruption and death threats, and of paedophilia, zoophilia and sadomasochism, and threatening suicide. A preliminary inquiry was closed in November 2012, as was the official's complaint for false accusation. Two people at the institute, including that official, suspected Salomon; the articles describe no search, seizure or charge. After an interview, Egora wrote, he had to surrender keys, a badge, a chequebook and a payment card and was escorted out. He wrote to Dautry that the steps were unexplained, brutal and disciplinary in appearance. William Dab, a former director-general of health then at the CNAM, told Dautry that staff had driven Salomon out "comme s'il s'agissait d'un délinquant". Those the paper contacted declined to comment.
Salomon denied any link to the letter. In the published lead of his lawyer's reply, Pierre-Olivier Sur called the dismissal "fluide" and said Salomon did not consider himself concerned by the inquiries. Egora quoted Sur as adding that nobody had implicated him, at Pasteur or elsewhere, that the letter had nothing to do with him, and that the exit became an agreed departure after which he kept good relations with the institute.
A decree of 3 January 2018, published in the Journal officiel the next day, appointed Jérôme Salomon, a university professor and hospital practitioner, director-general of health (directeur général de la santé) with effect from 8 January 2018, replacing Benoît Vallet. President Emmanuel Macron signed it after the Council of Ministers, on the report of Prime Minister Édouard Philippe and Agnès Buzyn, minister for solidarity and health; the post is one of the senior offices filled by decision of the Government under Article 13 of the Constitution.
The Direction générale de la santé reports directly to the health ministry and carries out the State's health decisions, seldom making major announcements of its own. Franceinfo described the director-general's work, in March 2020, as applying the minister's policy, running the administration and coordinating the health agencies, with health security as a principal mission, and treated the holder as the ministry's unofficial second-ranking official.
Buzyn was the minister until a decree of 16 February 2020 ended her functions at her request and appointed Olivier Véran minister for solidarity and health. Salomon remained director-general under Véran and the ministers who followed. He left the French post on 17 April 2023, the date on which the World Health Organization said his appointment as an assistant director-general took effect; Le Parisien reported that Monday as the day he vacated the directorate. A decree of 19 April 2023, countersigned by Prime Minister Élisabeth Borne and François Braun, minister of health and prevention, named Christian Rabaud, likewise a university professor and hospital practitioner, to succeed him with effect from 2 May 2023.
The agencies Franceinfo listed as falling within that coordination were Santé publique France, the medicines agency, the French Blood Establishment (Établissement français du sang) and the regional health agencies. An order of 23 November 2018 named Salomon an alternate representative of the minister responsible for health on the board of the Agence nationale de sécurité du médicament et des produits de santé. An order of 25 November 2019 then appointed him a full State member of the board of Santé publique France, in place of Anne-Claire Amprou.
On the international side, the provisional list of participants for the 142nd session of the WHO Executive Board, dated 22 January 2018, already recorded him as France's member, with the title of director-general of health at the ministry in Paris. The list for the 152nd session, dated 3 February 2023, still named Professor J. Salomon in that role at the Ministry of Health and Prevention. WHO's announcement of 17 April 2023 noted that he had been a member of the Executive Board up to his move onto the organization's headquarters staff.
Before the COVID-19 pandemic, the most visible alert of his first two years was measles. At a ministry briefing reported on 14 March 2018, Salomon warned that France could again face an epidemic on the scale of 2008–2012. Santé publique France had counted 913 cases since 6 November 2017; he said the virus stops circulating in a group only once vaccination coverage reaches about 95 percent, against about 79 percent among infants, and the agency urged two doses for people born from 1980 onward. Measles was one of eleven vaccines obligatory for children born from 1 January 2018, a requirement already in force when he took up the post. The agency's bulletin of 19 February 2020 later recorded 2,919 notified cases in 2018 and 2,636 in 2019, with 752 hospital admissions in 2019 and two deaths from subacute sclerosing panencephalitis in immunocompromised young adults; about 86 to 88 percent of the 2019 cases were in people who were unvaccinated or incompletely vaccinated.
The usable state reserve of surgical masks also shrank in these years, a point inquiries examined only after 2020. The National Assembly information report registered on 2 December 2020 found that the stock had stayed near 730 to 760 million units until 2018, then fell to about 100 million usable masks in 2019–2020, after September 2018 tests judged most undated lots non-compliant with standard EN 14683 and Santé publique France recommended on 3 October 2018 that Salomon have them destroyed. The report linked that fall to an earlier shift away from very large dormant reserves, including 2011 advice and a 2013 doctrine of the General Secretariat for Defence and National Security for employers outside health care; Salomon told the inquiry that guidance still distinguished surgical masks for symptomatic patients from FFP2 respirators for intensive care.
During the first months of the COVID-19 pandemic in France, Jérôme Salomon, director-general of health, gave the government’s regular epidemiological briefings. On 27 January 2020, with three confirmed cases of COVID-19, he told journalists in Paris that the updates fulfilled a commitment by the health minister, Agnès Buzyn, to a daily account of the epidemic.
On 3 February, with six confirmed cases that he described as stable and with no detected chain of transmission, he said there was “no epidemic in France” and “therefore no particular measure to take for the general public.” The format then settled into an evening slot, around 19:30, carried on continuous-news channels. Through the first lockdown he read out cases, deaths and hospital indicators that many households followed each night. In mid-March Olivier Véran, who had succeeded Buzyn, was filmed by France 2 saying he favoured ending “this count every evening,” which he called an “hourglass.” Once general confinement was in force, dropping that daily marker was no longer discussed.
The live evening briefings stopped after 1 May 2020 and were replaced by written communiqués on hospitalisations, intensive-care occupancy and deaths. The directorate-general of health told BFMTV that the change followed Salomon’s diary, then filled with meetings on the end of lockdown. Commentators quoted in the same report also read it as a way of separating the public message of reopening from the spokesman associated with the peak.
On 14 March Salomon announced that France had entered stage 3 of the national influenza-pandemic plan. He reported 4,500 confirmed cases and 91 deaths, including 838 new cases and 13 deaths in 24 hours, and a doubling of cases in 72 hours. The task, he said, was no longer to slow the virus’s arrival but to “delay, slow and flatten” the curve and to limit the load on care.
COVID-19 testing stayed narrow while laboratory capacity was short. On France Inter on the morning of 16 March—5,423 confirmed cases, about 400 people in intensive care and 127 deaths—he said tests covered hospitalised patients, severe cases and clusters, and that testing everyone would mean moving large numbers of people, including nurses. “There is not much point in getting tested,” he said; someone with a sore throat or headache should stay home rather than go to work out of “a spirit of bravery.”
The target was raised for the lifting of the first lockdown. At a National Assembly hearing on 23 April, Salomon said more than 165,000 PCR tests a week were then being done and that the aim was 700,000 a week from 11 May, for people with symptoms and their contacts. Véran had, days earlier, spoken of 500,000 tests a week.
Hospitals in the Grand Est were under acute pressure. That same 16 March interview had Salomon saying caregivers were “raising the alarm,” calling for a “general mobilisation,” and warning that a hospital could saturate quickly if contacts were not cut. To free intensive-care beds, the authorities moved ventilated patients out of the region. On 26 March a medicalised high-speed train left Strasbourg with 20 patients for the Pays de la Loire. The Pays de la Loire regional health agency described the train as a means prepared after the terrorist attacks of the mid-2010s; military aircraft and helicopters had already transferred other patients. Salomon’s briefings carried the national intensive-care count. The transfers were run by regional agencies, emergency-medical teams and interior-ministry crisis staff, not presented as a personal decision of the director-general.
On 11 March the Ministry of Solidarity and Health suspended all visits by outsiders to care homes for dependent elderly people (EHPAD) and to long-stay hospital units, leaving narrow exceptions to each director. Evening death tolls at first counted only deaths in hospital. On 2 April Salomon gave a first national figure of at least 884 deaths in nursing homes since the start of the epidemic, to be added to the hospital total. He had already said that hospital deaths were “probably a small share of mortality.”
Advice on masks changed while surgical and FFP2 stocks were tight. On 27 January Salomon recommended a mask for people who were ill and protective equipment only for caregivers. On 16 March he said caregivers would receive the state’s strategic stock, called masks “a precious commodity,” and said he had repeatedly denounced theft and misuse. Wearing a mask and gloves in the street, he said, “does not make much sense,” and masks “must remain reserved for caregivers.” The next day he again described masks as rare and to be kept for situations in which they were useful.
On 3 April, at the daily briefing, he said the authorities encouraged the public, if they wished, to wear masks, “in particular alternative masks” other than surgical or FFP2 models, together with the other barrier gestures. A Radio France investigation reported that health officials had treated wider use as potentially useful but had not said so while stocks could not supply both hospitals and the public without a run on what remained. On 23 April he told deputies that a general-public mask could help “in unavoidable situations of proximity” and was “a complementary measure, not ‘the mask or the rest.’”
Orders to stay at home were taken by the president and the government; Salomon argued for them in public-health terms and reported their context. On the morning of 16 March he said many people had not understood that they should remain at home, urged a sharp reduction in daily contacts, and pointed to the lockdown of Codogno, in Italy, as evidence that confinement and barrier measures could stop new cases. That evening Emmanuel Macron announced that from noon the next day, and for at least 15 days, movement in metropolitan France and overseas would be limited to essential trips—shopping, care, work that could not be done remotely, and exercise alone—with penalties for breaches. A decree of 16 March put those limits into law.
For the easing on 11 May, a decree required anyone aged 11 or older to wear a mask on public transport. On 20 July Véran announced that the obligation would extend to enclosed places open to the public. On 28 October Macron announced a second national lockdown, to begin in the night of Thursday to Friday and to last at least until 1 December.
COVID-19 vaccination began in France on 27 December 2020. Macron said that, after clearance by the health authorities, the first step would cover elderly people living in institutions and vulnerable health workers; the first product used was the Pfizer–BioNTech vaccine. Salomon’s later public role was to present surveillance figures rather than to set those priority groups. On 20 August 2021, citing a study by the official statistics directorate DREES for 2–8 August, he said vaccination was associated with about eight times fewer infections and an elevenfold lower risk of admission to critical care. The same study noted that fully vaccinated people were tested less often than unvaccinated people, which qualified a simple reading of the infection ratio.
France’s reserve of surgical masks, sized before the 2009 influenza pandemic at about one billion, still held 754 million at the end of 2017. Masks bought in 2005–2006 had no expiry date, and tests against the 2014 standard EN 14683, ordered in 2017 by Benoît Vallet, were finished only in September 2018. On 3 October François Bourdillon, head of Santé publique France, wrote to Jérôme Salomon that all 613 million undated masks had failed and should be treated as unusable, leaving 99 million valid masks, of which 63 million would expire at the end of 2019.
On 30 October 2018 Salomon ordered progressive destruction and the purchase of 50 million masks, plus 50 million more if savings on vaccine contracts allowed, an order the National Assembly later described as 100 million. It was placed in the summer of 2019. About 100 million masks were valid at the end of that year, including a first delivery of 32.7 million, beside some 360 million still awaiting destruction; early-2020 deliveries left 118 million adult masks immediately usable in February. Part of what had failed the standard, or expired in 2019, was later reassessed and issued.
A June 2018 email had already dropped the billion-mask target, and in September 2019 the direction told the agency not to rebuild the stock but to buy 20 million a year from 2021. Salomon called this a move from a perishable “dormant” stock to a rotating buffer. The idea predated him: the Haut Conseil de la santé publique discussed rotation in 2011, Vallet had raised a buffer stock in 2017, and Marisol Touraine told deputies she had refused it and left 754 million masks. FFP2 stocks, separately, had already fallen below a million by 2016, after a doctrine that employers should equip their own staff.
Agnès Buzyn told the Senate she was not informed of the non-conformity, the destruction or the limited repurchase. Her adviser Grégory Emery said that from October 2018 to 23 January 2020 he heard nothing about strategic mask stocks. The direction cited an unminuted meeting on 10 October 2018 but could not say whether the low target was put to the minister. She received the figures on 24 January 2020: 66 million adult and 33 million paediatric masks, with a further order due in February.
The Senate commission chaired by Alain Milon, with rapporteurs Catherine Deroche, Bernard Jomier and Sylvie Vermeillet, published Santé publique: pour un nouveau départ in December 2020. It called the shortage the symbol of unpreparedness and imputed it directly to the 2018 decision, while also tracing it to earlier choices. A firm order of 50 million, it said, did not even replace masks expiring in 2019, and buying a billion that October would have cost about 27 million euros, against about 450 million paid during the crisis.
On the opinion chaired by the Grenoble infectiologist Jean-Paul Stahl, the Senate compared an August 2018 draft, which tied a stock to supply capacity and a calculation of about a billion masks, with the text published in May 2019, which spoke only of a “need”. On 21 February 2019 Salomon asked Bourdillon to separate need from stock, writing that a suggestion of about a billion would sit badly beside what the agency held, and proposed centring the wording on “needs” so as to avoid rushed purchases. Bourdillon, who had invoked the experts’ independence, then wrote that he had removed any quantified stock, subject to their approval. The commission called this direct pressure to avoid disavowing the October order.
The direction answered on 10 December 2020 that “no pressure” had been applied, that Salomon had himself supplied every email, and that the contributors had accepted the edits. Olivier Véran said Salomon had told him that he had himself given the inquiry the emails. Stahl said he had never dealt with Salomon, that the published text reflected the group’s work in full, and that any pressure had changed nothing; he also told deputies that, personally, the minimum stock would be a billion if resupply were assured. Bruno Retailleau accused him of interfering with the experts. The commission did not refer the file to prosecutors: Deroche said that was not among the conclusions, Jomier said the Senate was not a court, and Milon called it an omission, not false testimony.
The Assembly report of 2 December 2020, by Éric Ciotti, placed the fall from about 754 million usable masks at the end of 2017 to 97 million at the end of 2019 inside a reduction running back to 2011. It accepted rotation in principle but said a small buffer required suppliers able to refill it quickly, which had not been secured. It recorded that on 26 February 2020 Salomon told senators that no shortage was to be feared, and that the first large surgical order, of 200 million, came only on 9 March. Salomon told the mission that FFP2 orders in early February were early given how few cases France then had.
On 15 October 2020 officers searched the homes and offices of Édouard Philippe, Véran, Buzyn, Salomon, Sibeth Ndiaye and Geneviève Chêne, and the premises of Santé publique France. The searches were ordered by the Cour de justice de la République in an investigation opened on 7 July 2020 for voluntary failure to combat a disaster and for endangering life; masks were the central issue among the complaints declared admissible. That court tries ministers for offences in office, not civil servants. Philippe, Buzyn and Véran were assisted witnesses. A placing of Buzyn under investigation for endangering life was annulled by the Court of Cassation, which found no specific statutory duty of prudence or safety. On 7 July 2025 the instruction ended in a general dismissal for Philippe, Buzyn and Véran, as the prosecutor-general, Rémy Heitz, had requested on 20 May.
The administrative cases concerned the state, not him. On 28 June 2022 the administrative tribunal of Paris found the state at fault both for an insufficient mask stock and for statements liable to discourage mask-wearing, but refused damages because no direct link to individual infections was shown. On 6 October 2023 the Paris administrative court of appeal upheld the faults, including the 2018 choice of a smaller stock without any assessment of hospital reserves or of supply, and allowed partial damages, as a loss of a chance, for some highly exposed people, among them the family of a doctor who died after working without masks. On 16 October 2025 the Conseil d'État set those rulings aside. It held that a strategic stock of 100 million surgical masks, with employers responsible for their staff, met the legal duty of preparation, and that later insufficiency for the whole population was not in itself a fault. The early public line — priority to the sick and to carers, then alternative masks — was judged consistent with the World Health Organization and the Haut Conseil in a global shortage, and the compensation claims failed.
On 17 April 2023 the World Health Organization named Jérôme Salomon Assistant Director-General for Universal Health Coverage, Communicable and Noncommunicable Diseases, with immediate effect. The post was one of five headquarters appointments in Geneva after Tedros Adhanom Ghebreyesus started a second term as Director-General; WHO said the leadership team had been consolidated around the 13th General Programme of Work.
Salomon was to oversee HIV, viral hepatitis and sexually transmitted infections, tuberculosis, malaria, neglected tropical diseases, mental health, substance use disorders, and noncommunicable diseases such as cardiovascular disease, diabetes, chronic respiratory diseases and cancer. He arrived from France's Ministry of Health and Prevention, where he was Director-General for Health, and had sat on the WHO Executive Board. Universal coverage was split across assistant directors-general. From 4 May 2023 Bruce Aylward led Universal Health Coverage, Life Course — primary health care, health systems, immunization, and reproductive, maternal and child health — while Ailan Li took Healthier Populations (environmental and social determinants, including tobacco, nutrition and climate). Yukiko Nakatani handled access to medicines and health products, and Hanan Balkhy kept antimicrobial resistance. Negotiation of a pandemic accord sat with Catharina Boehme, in external relations and governance, not with Salomon's disease division.
Before the United Nations General Assembly's September 2023 high-level meetings, Salomon joined Tedros and Aylward at a 14 September briefing in Geneva. Aylward warned that the world risked being no closer to universal coverage in 2030 without a shift to primary care and more spending. Salomon called tuberculosis one of the top infectious killers and, for the 22 September meeting, stressed equitable access to prevention and care, action on the epidemic's drivers, TB services within pandemic preparedness, and research. He urged high-level government attendance and said WHO would that week publish 2018–2022 progress against earlier political-declaration targets.
He addressed neglected tropical diseases in a recorded welcome to the 17th meeting of WHO's Strategic and Technical Advisory Group for those diseases, held at headquarters on 11–12 October 2023 under the theme "Accelerating towards 2030". The published overview quotes him describing NTDs as afflicting a billion of the most vulnerable people and linking their elimination to adaptable health systems and universal coverage: "Together, we can all catalyse change, ensure a world where nobody needlessly suffers from these afflictions and health is genuinely a universal right."
On 10 July 2024 he led a WHO delegation to the Chinese Center for Disease Control and Prevention. China CDC said the talks covered tuberculosis, HIV/AIDS, viral hepatitis and malaria, and that Salomon credited China's progress on those infections, other neglected tropical diseases and noncommunicable diseases, while calling for closer cooperation toward Healthy China 2030 and the Sustainable Development Goals. He co-chaired, for WHO, the fourth steering committee of the UN Health4Life Fund, a pooled fund with UNDP and UNICEF for country work on noncommunicable diseases and mental health, meeting from 10 to 13 December 2024. The committee reviewed progress since March and plans for 2025–26..pdf?sfvrsn=aed5b5fa_3&download=true)
The division did not survive the 2025 retrenchment. On 14 May, at the Programme, Budget and Administration Committee, Tedros cited lost United States funding and lower official development assistance elsewhere: a salary gap above US$500 million, a revised 2026–2027 budget of US$4.2 billion (from a US$5.3 billion proposal) and a remaining gap above US$1.7 billion. He said salary spending had to fall by about 25 percent, mostly at headquarters, and that senior management would drop from 14 posts to seven and departments from 76 to 34.
The executive team named that day, from 16 June, left Salomon out. Jeremy Farrar became Assistant Director-General for Health Promotion and Disease Prevention and Control, Yukiko Nakatani took health systems, Chikwe Ihekweazu succeeded Michael J. Ryan in emergencies, and Sylvie Briand became chief scientist. Tedros called the choices "extremely difficult and painful." The next day's statement thanked those leaving executive posts on 16 June — Ryan, Aylward, Samira Asma, Boehme, Li and Salomon — and credited Salomon with moving communicable diseases, noncommunicable diseases, mental health and neglected tropical diseases "across silos to better integrate services and strengthen health systems." Leaving the senior team was not an immediate exit. Health Policy Watch reported in December 2025 that Salomon left WHO in September, along with Ryan, who retired, and Asma, while Aylward, Li and Boehme took other WHO roles, amid cuts the outlet linked to the United States' January withdrawal.
With Olivier Lambotte, Salomon wrote Maladies infectieuses (Paris: Estem, 1999), a short practical text recorded in the French university-library authority file. In 1996 he completed Agents transmissibles non conventionnels et risque de transmission iatrogène, supervised by Gilles Brücker. His 2008 doctorate in clinical epidemiology at Pierre and Marie Curie University, Modification de l’usage antibiotique en population humaine et résistances bactériennes, supervised by Didier Guillemot, examined how changes in antibiotic use relate to antimicrobial resistance. During the 2009 H1N1 pandemic he and the virologist Bruno Lina published La vérité sur la grippe A H1N1: la prévention, le traitement, le vaccin, la gestion de l’épidémie (Paris: Éditions Frison-Roche, legal deposit 2009), with a preface by François Bricaire and collaboration from Danielle Sommer. He later prefaced Surveillance épidémiologique et veille sanitaire: principes, méthodes et applications en santé publique, by Pascal Astagneau and Pascal Crépey (Lavoisier Médecine Sciences), including a second edition.
Journal work from the Garches infectious-diseases service includes a 2006 prospective observational study in the Journal of Antimicrobial Chemotherapy. In adults with spinal-cord injury and neurogenic bladder who used intermittent catheterisation, a weekly oral cyclic antibiotic—one agent a week, alternated—was followed for at least two years. Symptomatic urinary infections fell from 9.4 to 1.8 per patient-year, and febrile episodes from 197 to 19; the authors reported no severe adverse events and no new colonisation by multidrug-resistant bacteria, and called the series a pilot.
By a decree of 13 July 2023, published in the Journal officiel of 14 July (NOR PRER2312789D), Salomon was named a knight of the Legion of Honour. Under the Ministry of Health and Prevention, at the grade of chevalier, the text lists “M. Salomon (Jérôme, Jean-René), professeur des universités-praticien hospitalier, ancien directeur général de la santé; 29 ans de services.” As with the other nominations in that decree, rank runs from the date the insignia are received.
After his post at the World Health Organization, Salomon moved into private preventive medicine. On 6 January 2026 Zoï announced that he would join the company. Agence France-Presse reported that the firm, created in 2021 by Ismaël Emelien, a former special adviser to President Emmanuel Macron, and by Paul Dupuy, said his task was to strengthen its medical governance and the scientific standard of its protocols. Zoï describes its offer as personalised preventive medicine. In practice, AFP reported, it sells high-end health assessments priced from one to several thousand euros, from a first centre in Paris between the Place Vendôme and the Opéra, and its website, the agency reported, envisaged further centres, especially outside France. In 2022 it raised €20 million from investors including Stéphane Bancel, chief executive of Moderna, Xavier Niel and Rodolphe Saadé of CMA CGM. What’s Up Doc described a flagship check-up, not reimbursed by statutory insurance, priced at up to €3,600.
The appointment reopened argument about price, access and the value of broad screening. Le Monde reported that fellow doctors questioned these “360-degree” preventive assessments offered by a private firm to which a former director-general of health had moved. In an opinion column, L’Express argued that tests going beyond what health authorities recommend amount to medicine for those who can pay more than €300 a month, and that abnormal results would still send patients into publicly financed imaging, biopsies and specialist care. Caducee.net placed the dispute in overdiagnosis and false positives when many markers and scans are used in people who feel well, referring to the benefit–risk standard of the Haute Autorité de santé and to follow-up tests falling on the reimbursed system. Le Canard enchaîné described the move as pantouflage and wrote that the aim was collective coverage of expensive check-ups. Salomon told What’s Up Doc that assessments at €3,600 were expensive and raised a legitimate debate, while defending a preventive model he said should extend beyond the private sector.
How the record is sourced and how the score is derived.
The score is formula-derived (Factrail formula v1, version 1.0.0), not an editorial verdict. Read the methodology.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute a fact on this pageNamed here, or represent someone who is? Request a right of reply.
Linked because the text names them, not because anything was measured.
Built from the indicator links of the drivers this text names. A profile of coverage, not a score.